Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study

Table 2 Imaging characteristics

Total number of patients	64
Imaging performed
PSMA PET/CT	64 (100%)
Bone scintigraphy
planar	64 (100%)
SPECT/CT	30 (47%)
MRI prostate^a	59 (92%)
CT abdomen
low dose	54 (84%)
contrast enhanced^b	10 (16%)
Conventional imaging and PET/CT interval, median (range)	49 days (−12 to 87)

^ain 5 patients no MRI available due to evident distant metastases on PSMA PET/CT [3], due to severe claustrophobia [1] and performed elsewhere [1]
^bdiagnostic abdominal CT with intravenous iodine-containing contrast in portal venous phase

ISSN: 1471-2407